Ocular Surface

Papers
(The H4-Index of Ocular Surface is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Editorial Board127
In vivo calcium imaging of corneal sensory nerves with fluorescent stereoscopic microscopy107
Reassessing interdisciplinary approaches to belantamab mafodotin-induced ocular toxicity: Towards a standardized collaborative model104
Biology and medicine on ocular surface restoration: Advancements and limits of limbal stem cell deficiency treatments74
Long term study of topical interferon α-2b eye drops as primary treatment of ocular surface squamous neoplasia72
Atypical microbial keratitis69
Monkeypox and ocular implications in humans66
Safety of subconjunctival injection of mesenchymal stromal cells in persistent corneal epithelial disease – A phase 1b clinical trial61
Endogenous TSG-6 modulates corneal inflammation following chemical injury56
Corrigendum to “New insights into lacrimal gland anatomy using 7T MRI and electron microscopy: Relevance for lacrimal gland targeted therapies and bioengineering” [Ocul. Surf. 30 (October 2023) 204–2155
Economic burden of keratitis patients with inpatient care: a nationwide, multicenter registry study53
Development and validation of a method to generate phenol red thread tests52
Readership awareness series – Paper 10: Open Access Publishing49
Mechanistic insights into conjunctivalization in limbal stem cell deficiency using a lineage tracing approach48
A pilot randomized controlled trial of topical androgen treatment in dry eye46
Metabolic reprogramming in lacrimal gland GVHD: Stage-specific shifts in acinar cells as drivers of disease progression46
The clinical outcomes of minor salivary gland transplantation for severe dry eye disease secondary to chronic Stevens-Johnson syndrome44
Editorial Board44
A prospective self-controlled study on the alterations of the ocular surface and conjunctival transcriptomic profile associated with prolonged exposure to video display terminals43
Organotypic culture model of mouse meibomian gland as a screening platform for risk factors related to meibomian gland dysfunction43
Modulating the tachykinin: Role of substance P and neurokinin receptor expression in ocular surface disorders42
Predatory bacteria can reduce Pseudomonas aeruginosa induced corneal perforation and proliferation in a rabbit keratitis model39
New disposable esthesiometer (KeraSenseⓇ) to improve diagnosis and management of neurotrophic keratitis38
Diagnostic performance and optimal cut-off values for tear film lipid layer grading and thickness in dry eye disease: An investigator-masked, randomised crossover study36
Epidemiology and risk factors for the development of cicatrizing conjunctivitis in chronic ocular graft-versus-host disease35
Tear film changes in symptomatic versus asymptomatic video display terminal users following computer challenge test35
Chronic inflammation as a proposed risk factor for ocular surface squamous neoplasia34
Allogeneic mesenchymal stem cell therapy for dry eye disease in patients with Sjögren's syndrome: A randomized clinical trial31
Effects of age on lacrimal gland bioactive lipids31
Corneal gene therapy: Structural and mechanistic understanding31
Cytokine levels and clinical characteristics in the tear fluid of patients with atopic dermatitis and atopic keratoconjunctivitis30
A loss of inter-α-inhibitor Heavy Chain 5 (ITIH5) leads to corneal thinning and increased corneal inflammation following injury and early onset geriatric decline30
Herpes simplex virus, varicella-zoster virus and cytomegalovirus keratitis: Facts for the clinician30
0.24281811714172